Final results of prospective treatment with pegylated interferon alfa-2a for patients with polycythemia vera and essential thrombocythemia in first and second-line settings Meeting Abstract
| Authors: | Yacoub, A.; Mascarenhas, J.; Mesa, R. A.; Kosiorek, H. E.; Rampal, R. K.; Silver, R. T.; Salama, M. E.; Siwoski, O.; Dueck, A. C.; Sandy, L.; McMullin, M. F.; Ewing, J.; O'Connell, C. L.; Mead, A. J.; De Stefano, V.; Weinberg, R. S.; Baer, M. R.; Kessler, C. M.; Winton, E. F.; Vannucchi, A. M.; Kremyanskaya, M.; Vadakara, J.; Rosti, V.; Hexner, E. O.; Rondelli, D.; Arcasoy, M. O.; Rambaldi, A.; Ritchie, E. K.; Barbui, T.; Kiladjian, J. J.; Harrison, C. N.; Prchal, J. T.; Hoffman, R. |
| Abstract Title: | Final results of prospective treatment with pegylated interferon alfa-2a for patients with polycythemia vera and essential thrombocythemia in first and second-line settings |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160407068 |
| DOI: | 10.1182/blood-2019-124865 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2943 -- Source: Wos |
